You are here:
Company

Sabiad

Back to overview

Sabiad focuses on developing localised theranostic solutions that completely transform the way bacterial infections are diagnosed and treated. They combine precision imaging with targeted interventions to improve patient outcomes.

Sabiad belongs to the fund:

Pharma Connect Capital">

Investment fund Pharma Connect Capital (PCC) invests in very early-stage medicine development, drug delivery and biomarkers from the High Throughput Screening phase up to Phase 1 (sometimes Phase 2) and other projects...

View all the funds from the IFG

Arches Capital is a fast growing group of business angels that is bridging the gap between Venture Capitalist (VCs) and...
Lumo Labs creates opportunities for impact-driven ventures in emerging technologies....